These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37376827)

  • 1. Cannabidiol as a Harm Reduction Strategy for People Who Use Drugs: A Rapid Review.
    Lo LA; MacCallum CA; Nanson K; Koehn M; Mitchell I; Milloy MJ; Walsh Z; Fehr F
    Can J Psychiatry; 2023 Aug; 68(8):557-571. PubMed ID: 37376827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial.
    Hurd YL; Spriggs S; Alishayev J; Winkel G; Gurgov K; Kudrich C; Oprescu AM; Salsitz E
    Am J Psychiatry; 2019 Nov; 176(11):911-922. PubMed ID: 31109198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of cannabidiol in anxiety and anxiety-related disorders.
    Skelley JW; Deas CM; Curren Z; Ennis J
    J Am Pharm Assoc (2003); 2020; 60(1):253-261. PubMed ID: 31866386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabidiol in the context of substance use disorder treatment: A systematic review.
    Paulus V; Billieux J; Benyamina A; Karila L
    Addict Behav; 2022 Sep; 132():107360. PubMed ID: 35580370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A scoping review of the use of cannabidiol in psychiatric disorders.
    Kirkland AE; Fadus MC; Gruber SA; Gray KM; Wilens TE; Squeglia LM
    Psychiatry Res; 2022 Feb; 308():114347. PubMed ID: 34952255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use and perceptions of Cannabidiol among individuals in treatment for opioid use disorder.
    Kudrich C; Chen R; Meng Y; Bachi K; Hurd YL
    Harm Reduct J; 2024 Jul; 21(1):135. PubMed ID: 39020418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabidiol (CBD) use in psychiatric disorders: A systematic review.
    Bonaccorso S; Ricciardi A; Zangani C; Chiappini S; Schifano F
    Neurotoxicology; 2019 Sep; 74():282-298. PubMed ID: 31412258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the potential use of cannabidiol in the treatment of cocaine use disorder: A systematic review.
    Rodrigues LA; Caroba MES; Taba FK; Filev R; Gallassi AD
    Pharmacol Biochem Behav; 2020 Sep; 196():172982. PubMed ID: 32645315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managed alcohol as a harm reduction intervention for alcohol addiction in populations at high risk for substance abuse.
    Muckle W; Muckle J; Welch V; Tugwell P
    Cochrane Database Syst Rev; 2012 Dec; 12():CD006747. PubMed ID: 23235633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabidiol in Anxiety and Sleep: A Large Case Series.
    Shannon S; Lewis N; Lee H; Hughes S
    Perm J; 2019; 23():18-041. PubMed ID: 30624194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cannabidiol in cannabis flower: Implications for harm reduction.
    Gibson LP; Karoly HC; Ellingson JM; Klawitter J; Sempio C; Squeri JE; Bryan AD; Bidwell LC; Hutchison KE
    Addict Biol; 2022 Jan; 27(1):e13092. PubMed ID: 34467598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabidiol as a treatment for craving and relapse in individuals with cocaine use disorder: a randomized placebo-controlled trial.
    Mongeau-Pérusse V; Brissette S; Bruneau J; Conrod P; Dubreucq S; Gazil G; Stip E; Jutras-Aswad D
    Addiction; 2021 Sep; 116(9):2431-2442. PubMed ID: 33464660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial.
    Schoedel KA; Szeto I; Setnik B; Sellers EM; Levy-Cooperman N; Mills C; Etges T; Sommerville K
    Epilepsy Behav; 2018 Nov; 88():162-171. PubMed ID: 30286443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substituting Cannabidiol for Opioids and Pain Medications Among Individuals With Fibromyalgia: A Large Online Survey.
    Boehnke KF; Gagnier JJ; Matallana L; Williams DA
    J Pain; 2021 Nov; 22(11):1418-1428. PubMed ID: 33992787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle.
    Gonzalez-Cuevas G; Martin-Fardon R; Kerr TM; Stouffer DG; Parsons LH; Hammell DC; Banks SL; Stinchcomb AL; Weiss F
    Neuropsychopharmacology; 2018 Sep; 43(10):2036-2045. PubMed ID: 29686308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome.
    Lattanzi S; Trinka E; Striano P; Rocchi C; Salvemini S; Silvestrini M; Brigo F
    CNS Drugs; 2021 Mar; 35(3):265-281. PubMed ID: 33754312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabidiol Effect on Cue-Induced Craving for Individuals with Opioid Use Disorder Treated with Buprenorphine: A Small Proof-of-Concept Open-Label Study.
    Suzuki J; Martin B; Prostko S; Chai PR; Weiss RD
    Integr Med Rep; 2022 Aug; 1(1):157-163. PubMed ID: 36105269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabidiol Treatment Might Promote Resilience to Cocaine and Methamphetamine Use Disorders: A Review of Possible Mechanisms.
    Calpe-López C; García-Pardo MP; Aguilar MA
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31315244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.